CCND1 and osteosarcoma: In addition, Yi et al. confirmed that SP cells were contained in osteosarcoma samples and β-catenin and cyclin D1 were highly upregulated in them, indicating that this pathway is a potential target of novel anticancer drugs for osteosarcoma stem cells [65].